Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

especially if your allergies are chronic. The answer, though, will depend on the ‌kind‌ of antihistamine you take. Here, ...

Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...

to twice-daily azelastine (an intranasal antihistamine), fluticasone propionate, the combination of the two, or placebo for 2 weeks during the allergy season; all treatments were administered as ...